{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:48:10Z","timestamp":1791946090775,"version":"4.3.4"},"reference-count":282,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/nrneph.2017.52","type":"journal-article","created":{"date-parts":[[2017,4,23]],"date-time":"2017-04-23T23:21:09Z","timestamp":1492989669000},"page":"344-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":443,"title":["The systemic nature of CKD"],"prefix":"10.1038","volume":"13","author":[{"given":"Carmine","family":"Zoccali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Vanholder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Sarafidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedo W.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Fliser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Fouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitty J.","family":"Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Wiecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association \u2013 European Dialysis Transplantation Association (ERA-EDTA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"BFnrneph201752_CR1","unstructured":"KDIGO. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3, 19\u201362 (2013)."},{"key":"BFnrneph201752_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","volume":"382","author":"K-U Eckardt","year":"2013","unstructured":"Eckardt, K.-U. et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382, 158\u2013169 (2013).","journal-title":"Lancet"},{"key":"BFnrneph201752_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.ajkd.2010.03.012","volume":"56","author":"JW MacCluer","year":"2010","unstructured":"MacCluer, J. W. et al. Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project. Am. J. Kidney Dis. 56, 289\u2013302 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201752_CR4","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.2215\/CJN.06770711","volume":"6","author":"C Barrett Bowling","year":"2011","unstructured":"Barrett Bowling, C. et al. Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications. Clin. J. Am. Soc. Nephrol. 6, 2822\u20132828 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/med\/9780199592548.003.0107","volume-title":"Oxord Textbook of Clinical Nephrology","author":"C Zoccali","year":"2015","unstructured":"Zoccali, C., Bolignano, D. & Mallamaci, F. in Oxord Textbook of Clinical Nephrology 4th edn Ch. 107 (eds Turner, N. N. et al.) 837\u2013852 (Oxford Univ. Press, 2015)."},{"key":"BFnrneph201752_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1681\/ASN.2014121188","volume":"27","author":"OH Maarouf","year":"2015","unstructured":"Maarouf, O. H. et al. Paracrine Wnt1 drives interstitial fibrosis without inflammation by tubulointerstitial cross-talk. J. Am. Soc. Nephrol. 27, 781\u2013790 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR7","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1373\/clinchem.2005.055665","volume":"51","author":"NA Abbas","year":"2005","unstructured":"Abbas, N. A. et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin. Chem. 51, 2059\u20132066 (2005).","journal-title":"Clin. Chem."},{"key":"BFnrneph201752_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1053\/j.ajkd.2005.06.017","volume":"46","author":"S Vickery","year":"2005","unstructured":"Vickery, S. et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am. J. Kidney Dis. 46, 610\u2013620 (2005).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201752_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.amjcard.2011.03.056","volume":"108","author":"WHW Tang","year":"2011","unstructured":"Tang, W. H. W. et al. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. Am. J. Cardiol. 108, 385\u2013390 (2011).","journal-title":"Am. J. Cardiol."},{"key":"BFnrneph201752_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2015.156","volume":"88","author":"P Evenepoel","year":"2015","unstructured":"Evenepoel, P., D'Haese, P. & Brandenburg, V. Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int. 88, 235\u2013240 (2015).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/ki.2014.425","volume":"87","author":"M Ketteler","year":"2015","unstructured":"Ketteler, M. et al. Revisiting KDIGO clinical practice guideline on chronic kidney disease \u2014 mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int. 87, 502\u2013528 (2015).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/kisup.2011.4","volume":"1","author":"C Zoccali","year":"2011","unstructured":"Zoccali, C. et al. The complexity of the cardio\u2013renal link: taxonomy, syndromes, and diseases. Kidney Int. Suppl. 1, 2\u20135 (2011).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrneph201752_CR13","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/ndt\/gft514","volume":"29","author":"M Cozzolino","year":"2014","unstructured":"Cozzolino, M. et al. Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome? Nephrol. Dial. Transplant. 29, 1815\u20131820 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR14","volume-title":"The Stanford Encyclopedia of Philosophy","author":"I Brigandt","year":"2017","unstructured":"Brigandt, I. & Love, A. in The Stanford Encyclopedia of Philosophy (ed. Zalta, E. N.) (Stanford Univ., 2017)."},{"key":"BFnrneph201752_CR15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/eurjhf\/hfs056","volume":"14","author":"IC Macdougall","year":"2012","unstructured":"Macdougall, I. C. et al. Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency. Eur. J. Heart Fail. 14, 882\u2013886 (2012).","journal-title":"Eur. J. Heart Fail."},{"key":"BFnrneph201752_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/qjmed\/hcq057","volume":"103","author":"MJ Beresford","year":"2010","unstructured":"Beresford, M. J. Medical reductionism: lessons from the great philosophers. QJM 103, 721\u2013724 (2010).","journal-title":"QJM"},{"key":"BFnrneph201752_CR17","unstructured":"Hektoen International. Richard Bright, the father of nephrology. HekInt.orghttp:\/\/www.hektoeninternational.org\/index.php?option=com_content&view=article&id=705 (2013)."},{"key":"BFnrneph201752_CR18","first-page":"211","volume-title":"Strauss and Welt's Diseases of the Kidney","author":"DW Seldin","year":"1971","unstructured":"Seldin, D. W., Carter, N. W. & Rector, F. C. in Strauss and Welt's Diseases of the Kidney Vol. 2 (eds Strauss, M. B. & Welt, L. G.) 211\u2013272 (Little Brown Co.,1971)."},{"key":"BFnrneph201752_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2796.2010.02218.x","volume":"267","author":"RH Straub","year":"2010","unstructured":"Straub, R. H., Cutolo, M., Buttgereit, F. & Pongratz, G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J. Intern. Med. 267, 543\u2013560 (2010).","journal-title":"J. Intern. Med."},{"key":"BFnrneph201752_CR20","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/oby.2008.334","volume":"16","author":"PJ Manning","year":"2008","unstructured":"Manning, P. J. et al. Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity (Silver Spring) 16, 2046\u20132052 (2008).","journal-title":"Obesity (Silver Spring)"},{"key":"BFnrneph201752_CR21","doi-asserted-by":"publisher","first-page":"11533","DOI":"10.1073\/pnas.89.23.11533","volume":"89","author":"RL Walford","year":"1992","unstructured":"Walford, R. L., Harris, S. B. & Gunion, M. W. The calorically restricted low-fat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol, and blood pressure in humans. Proc. Natl Acad. Sci. USA 89, 11533\u201311537 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201752_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1189\/jlb.0108024","volume":"84","author":"NJ Maciver","year":"2008","unstructured":"Maciver, N. J. et al. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J. Leukoc. Biol. 84, 949\u2013957 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph201752_CR23","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.4049\/jimmunol.172.8.4661","volume":"172","author":"KA Frauwirth","year":"2004","unstructured":"Frauwirth, K. A. & Thompson, C. B. Regulation of T lymphocyte metabolism. J. Immunol. 172, 4661\u20134665 (2004).","journal-title":"J. Immunol."},{"key":"BFnrneph201752_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tem.2010.10.002","volume":"22","author":"F Mauvais-Jarvis","year":"2011","unstructured":"Mauvais-Jarvis, F. Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol. Metab. 22, 24\u201333 (2011).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnrneph201752_CR25","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00125-011-2155-z","volume":"54","author":"P Ducy","year":"2011","unstructured":"Ducy, P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 54, 1291\u20131297 (2011).","journal-title":"Diabetologia"},{"key":"BFnrneph201752_CR26","doi-asserted-by":"publisher","first-page":"E286","DOI":"10.1152\/ajpendo.00201.2001","volume":"282","author":"MC Moore","year":"2002","unstructured":"Moore, M. C. et al. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 282, E286\u2013E296 (2002).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrneph201752_CR27","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1210\/jc.2007-0445","volume":"92","author":"JJ Christiansen","year":"2009","unstructured":"Christiansen, J. J. et al. Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure. J. Clin. Endocrinol. Metab. 92, 3553\u20133559 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph201752_CR28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1210\/en.2011-1979","volume":"153","author":"BJ Jones","year":"2012","unstructured":"Jones, B. J., Tan, T. & Bloom, S. R. Minireview: glucagon in stress and energy homeostasis. Endocrinology 153, 1049\u20131054 (2012).","journal-title":"Endocrinology"},{"key":"BFnrneph201752_CR29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s11481-015-9601-5","volume":"10","author":"CA B\u00e1ez-Pag\u00e1n","year":"2015","unstructured":"B\u00e1ez-Pag\u00e1n, C. A., Delgado-V\u00e9lez, M. & Lasalde-Dominicci, J. A. Activation of the macrophage \u03b17 nicotinic acetylcholine receptor and control of inflammation. J. Neuroimmune Pharmacol. 10, 468\u2013476 (2015).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"BFnrneph201752_CR30","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1084\/jem.20120571","volume":"209","author":"U Andersson","year":"2012","unstructured":"Andersson, U. & Tracey, K. J. Neural reflexes in inflammation and immunity. J. Exp. Med. 209, 1057\u20131068 (2012).","journal-title":"J. Exp. Med."},{"key":"BFnrneph201752_CR31","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1161\/01.CIR.96.11.4104","volume":"96","author":"U Scherrer","year":"1997","unstructured":"Scherrer, U. & Sartori, C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 96, 4104\u20134113 (1997).","journal-title":"Circulation"},{"key":"BFnrneph201752_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","volume":"4","author":"L Rui","year":"2014","unstructured":"Rui, L. Energy metabolism in the liver. Compr. Physiol. 4, 177\u2013197 (2014).","journal-title":"Compr. Physiol."},{"key":"BFnrneph201752_CR33","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/art.20987","volume":"52","author":"P H\u00e4rle","year":"2005","unstructured":"H\u00e4rle, P., M\u00f6bius, D., Carr, D. J. J., Sch\u00f6lmerich, J. & Straub, R. H. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum. 52, 1305\u20131313 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201752_CR34","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1523-1755.2005.00172.x","volume":"67","author":"R Mehrotra","year":"2005","unstructured":"Mehrotra, R. et al. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int. 67, 1070\u20131077 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR35","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2215\/CJN.03500412","volume":"7","author":"J Gupta","year":"2012","unstructured":"Gupta, J. et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin. J. Am. Soc. Nephrol. 7, 1938\u20131946 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR36","first-page":"62","volume":"23","author":"S Cottone","year":"2010","unstructured":"Cottone, S. et al. Relationship of fetuin-A with glomerular filtration rate and endothelial dysfunction in moderate\u2013severe chronic kidney disease. J. Nephrol. 23, 62\u201369 (2010).","journal-title":"J. Nephrol."},{"key":"BFnrneph201752_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1053\/j.ajkd.2012.11.051","volume":"62","author":"P Stenvinkel","year":"2013","unstructured":"Stenvinkel, P. & Larsson, T. E. Chronic kidney disease: a clinical model of premature aging. Am. J. Kidney Dis. 62, 339\u2013351 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201752_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ndt\/gfh1054","volume":"19","author":"R Schindler","year":"2004","unstructured":"Schindler, R. Causes and therapy of microinflammation in renal failure. Nephrol. Dial. Transplant. 19, 34\u201340 (2004).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.ki.5002343","volume":"72","author":"AS Levey","year":"2007","unstructured":"Levey, A. S. et al. Chronic kidney disease as a global public health problem: approaches and initiatives \u2014 a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 72, 247\u2013259 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2215\/CJN.05470610","volume":"6","author":"H Akar","year":"2011","unstructured":"Akar, H., Akar, G. C., Carrero, J. J., Stenvinkel, P. & Lindholm, B. Systemic consequences of poor oral health in chronic kidney disease patients. Clin. J. Am. Soc. Nephrol. 6, 218\u2013226 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR41","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/ndt\/gfg074","volume":"18","author":"F Locatelli","year":"2003","unstructured":"Locatelli, F. et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol. Dial. Transplant. 18, 1272\u20131280 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR42","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/ATVBAHA.115.305896","volume":"35","author":"SE Gardner","year":"2015","unstructured":"Gardner, S. E., Humphry, M., Bennett, M. R. & Clarke, M. C. H. Senescent vascular smooth muscle cells drive inflammation through an interleukin-1\u03b1-dependent senescence-associated secretory phenotype. Arterioscler. Thromb. Vasc. Biol. 35, 1963\u20131974 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph201752_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1681\/ASN.2008060664","volume":"20","author":"JJ Carrero","year":"2009","unstructured":"Carrero, J. J. et al. Low serum testosterone increases mortality risk among male dialysis patients. J. Am. Soc. Nephrol. 20, 613\u2013620 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR44","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1038\/ki.2009.401","volume":"76","author":"H Vlassara","year":"2009","unstructured":"Vlassara, H. et al. Role of oxidants\/inflammation in declining renal function in chronic kidney disease and normal aging. Kidney Int. Suppl. 76, S3\u2013S11 (2009).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrneph201752_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ndt\/gfs133","volume":"28","author":"C-Y Sun","year":"2013","unstructured":"Sun, C.-Y., Hsu, H.-H. & Wu, M.-S. p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells. Nephrol. Dial. Transplant. 28, 70\u201378 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR46","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1540-8175.2007.00589.x","volume":"25","author":"AK Rao","year":"2008","unstructured":"Rao, A. K. et al. Left atrial volume is associated with inflammation and atherosclerosis in patients with kidney disease. Echocardiography 25, 264\u2013269 (2008).","journal-title":"Echocardiography"},{"key":"BFnrneph201752_CR47","doi-asserted-by":"publisher","first-page":"601424","DOI":"10.1155\/2013\/601424","volume":"2013","author":"TR de Nadai","year":"2013","unstructured":"de Nadai, T. R. et al. Metabolic acidosis treatment as part of a strategy to curb inflammation. Int. J. Inflam. 2013, 601424 (2013).","journal-title":"Int. J. Inflam."},{"key":"BFnrneph201752_CR48","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00198-015-3233-8","volume":"27","author":"L Viaene","year":"2016","unstructured":"Viaene, L. et al. Inflammation and the bone\u2013vascular axis in end-stage renal disease. Osteoporos. Int. 27, 489\u2013497 (2016).","journal-title":"Osteoporos. Int."},{"key":"BFnrneph201752_CR49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2016.05.044","volume":"251","author":"P Aghagolzadeh","year":"2016","unstructured":"Aghagolzadeh, P. et al. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-\u03b1. Atherosclerosis 251, 404\u2013414 (2016).","journal-title":"Atherosclerosis"},{"key":"BFnrneph201752_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/apha.12727","volume":"219","author":"CF Underwood","year":"2016","unstructured":"Underwood, C. F. et al. Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease? Acta Physiol. (Oxf.) 219, 305\u2013323 (2016).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"BFnrneph201752_CR51","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/ki.2015.305","volume":"88","author":"SS Thomas","year":"2015","unstructured":"Thomas, S. S., Zhang, L. & Mitch, W. E. Molecular mechanisms of insulin resistance in chronic kidney disease. Kidney Int. 88, 1233\u20131239 (2015).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR52","doi-asserted-by":"publisher","first-page":"616","DOI":"10.2215\/CJN.08510815","volume":"11","author":"A Meyring-W\u00f6sten","year":"2016","unstructured":"Meyring-W\u00f6sten, A. et al. Intradialytic hypoxemia and clinical outcomes in patients on hemodialysis. Clin. J. Am. Soc. Nephrol. 11, 616\u2013625 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR53","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2215\/CJN.07000714","volume":"10","author":"B Spoto","year":"2015","unstructured":"Spoto, B. et al. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD. Clin. J. Am. Soc. Nephrol. 10, 232\u2013240 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR54","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1365-2796.2007.01777.x","volume":"261","author":"P Stenvinkel","year":"2007","unstructured":"Stenvinkel, P. et al. Impact of inflammation on epigenetic DNA methylation \u2014 a novel risk factor for cardiovascular disease? J. Intern. Med. 261, 488\u2013499 (2007).","journal-title":"J. Intern. Med."},{"key":"BFnrneph201752_CR55","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/thy.1995.5.481","volume":"5","author":"JE Silva","year":"1995","unstructured":"Silva, J. E. Thyroid hormone control of thermogenesis and energy balance. Thyroid 5, 481\u2013492 (1995).","journal-title":"Thyroid"},{"key":"BFnrneph201752_CR56","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1681\/ASN.2005040356","volume":"16","author":"C Zoccali","year":"2005","unstructured":"Zoccali, C., Tripepi, G., Cutrupi, S., Pizzini, P. & Mallamaci, F. Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J. Am. Soc. Nephrol. 16, 2789\u20132795 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR57","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrneph.2013.170","volume":"9","author":"CL Meuwese","year":"2013","unstructured":"Meuwese, C. L., Dekkers, O. M., Stenvinkel, P., Dekker, F. W. & Carrero, J. J. Nonthyroidal illness and the cardiorenal syndrome. Nat. Rev. Nephrol. 9, 599\u2013609 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201752_CR58","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/HYPERTENSIONAHA.109.142042","volume":"55","author":"SP Levick","year":"2010","unstructured":"Levick, S. P., Murray, D. B., Janicki, J. S. & Brower, G. L. Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertension 55, 270\u2013276 (2010).","journal-title":"Hypertension"},{"key":"BFnrneph201752_CR59","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2217\/fmb.13.165","volume":"9","author":"D Mafra","year":"2014","unstructured":"Mafra, D. et al. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol. 9, 399\u2013410 (2014).","journal-title":"Future Microbiol."},{"key":"BFnrneph201752_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ki.2015.255","volume":"88","author":"L Koppe","year":"2015","unstructured":"Koppe, L., Mafra, D. & Fouque, D. Probiotics and chronic kidney disease. Kidney Int. 88, 1\u20139 (2015).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR61","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-0897-4_9","volume":"817","author":"P Holzer","year":"2014","unstructured":"Holzer, P. & Farzi, A. Neuropeptides and the microbiota\u2013gut\u2013brain axis. Adv. Exp. Med. Biol. 817, 195\u2013219 (2014).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrneph201752_CR62","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00467-007-0533-z","volume":"22","author":"HL Lai","year":"2007","unstructured":"Lai, H. L., Kartal, J. & Mitsnefes, M. Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor-\u03b1. Pediatr. Nephrol. 22, 1751\u20131756 (2007).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201752_CR63","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1093\/ndt\/gfq817","volume":"26","author":"M Landau","year":"2011","unstructured":"Landau, M. et al. Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol. Dial. Transplant. 26, 2814\u20132819 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR64","first-page":"464","volume":"18","author":"F Mallamaci","year":"2005","unstructured":"Mallamaci, F., Tripepi, G. & Zoccali, C. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system. J. Nephrol. 18, 464\u2013468 (2005).","journal-title":"J. Nephrol."},{"key":"BFnrneph201752_CR65","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1507\/endocrj.EJ12-0032","volume":"59","author":"DE Yoo","year":"2012","unstructured":"Yoo, D. E. et al. Low circulating adiponectin levels are associated with insulin resistance in non-obese peritoneal dialysis patients. Endocr. J. 59, 685\u2013695 (2012).","journal-title":"Endocr. J."},{"key":"BFnrneph201752_CR66","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJM197806082982306","volume":"298","author":"L Landsberg","year":"1978","unstructured":"Landsberg, L. & Young, J. B. Fasting, feeding and regulation of the sympathetic nervous system. N. Engl. J. Med. 298, 1295\u20131301 (1978).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201752_CR67","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.atherosclerosis.2011.05.031","volume":"219","author":"Y Yano","year":"2011","unstructured":"Yano, Y. et al. Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients. Atherosclerosis 219, 273\u2013279 (2011).","journal-title":"Atherosclerosis"},{"key":"BFnrneph201752_CR68","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.ki.5002585","volume":"73","author":"D Fouque","year":"2008","unstructured":"Fouque, D. et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 73, 391\u2013398 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR69","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajkd.2003.07.016","volume":"42","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh, K., Ikizler, T. A., Block, G., Avram, M. M. & Kopple, J. D. Malnutrition\u2013inflammation complex syndrome in dialysis patients: causes and consequences. Am. J. Kidney Dis. 42, 864\u2013881 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201752_CR70","doi-asserted-by":"publisher","first-page":"e0124772","DOI":"10.1371\/journal.pone.0124772","volume":"10","author":"J Gupta","year":"2015","unstructured":"Gupta, J. et al. Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study. PLoS ONE 10, e0124772 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrneph201752_CR71","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1365-2362.2003.01169.x","volume":"33","author":"C Zoccali","year":"2003","unstructured":"Zoccali, C. et al. Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. Eur. J. Clin. Invest. 33, 561\u2013566 (2003).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFnrneph201752_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.HYP.0000022063.50739.60","volume":"40","author":"C Zoccali","year":"2002","unstructured":"Zoccali, C. et al. Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension 40, 41\u201346 (2002).","journal-title":"Hypertension"},{"key":"BFnrneph201752_CR73","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1097\/00004872-200307000-00025","volume":"21","author":"C Zoccali","year":"2003","unstructured":"Zoccali, C. et al. Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease. J. Hypertens. 21, 1355\u20131362 (2003).","journal-title":"J. Hypertens."},{"key":"BFnrneph201752_CR74","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/hc1102.105261","volume":"105","author":"C Zoccali","year":"2002","unstructured":"Zoccali, C. et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105, 1354\u20131359 (2002).","journal-title":"Circulation"},{"key":"BFnrneph201752_CR75","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1097\/01.ASN.0000089026.28617.33","volume":"14","author":"C Zoccali","year":"2003","unstructured":"Zoccali, C. et al. Prospective study of neuropeptide Y as an adverse cardiovascular risk factor in end-stage renal disease. J. Am. Soc. Nephrol. 14, 2611\u20132617 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR76","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig, H. K. & Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med. 364, 656\u2013665 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201752_CR77","doi-asserted-by":"publisher","first-page":"H285","DOI":"10.1152\/ajpheart.00560.2006","volume":"292","author":"E O'Riordan","year":"2007","unstructured":"O'Riordan, E. et al. Chronic NOS inhibition actuates endothelial\u2013mesenchymal transformation. Am. J. Physiol. Heart Circ. Physiol. 292, H285\u2013H294 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrneph201752_CR78","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/01.ASN.0000034910.58454.FD","volume":"13","author":"D-H Kang","year":"2002","unstructured":"Kang, D.-H. et al. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 13, 806\u2013816 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR79","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrneph.2013.35","volume":"9","author":"T Tanaka","year":"2013","unstructured":"Tanaka, T. & Nangaku, M. Angiogenesis and hypoxia in the kidney. Nat. Rev. Nephrol. 9, 211\u2013222 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201752_CR80","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1542-4758.2009.00342.x","volume":"13","author":"S Hussain","year":"2009","unstructured":"Hussain, S. et al. Outcome among patients with acute renal failure needing continuous renal replacement therapy: a single center study. Hemodial. Int. 13, 205\u2013214 (2009).","journal-title":"Hemodial. Int."},{"key":"BFnrneph201752_CR81","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/ndt\/gfn657","volume":"24","author":"G Boll\u00e9e","year":"2009","unstructured":"Boll\u00e9e, G. et al. Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib. Nephrol. Dial. Transplant. 24, 682\u2013685 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR82","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1525-139X.2009.00590.x","volume":"22","author":"ZA Massy","year":"2009","unstructured":"Massy, Z. A., Stenvinkel, P. & Drueke, T. B. The role of oxidative stress in chronic kidney disease. Semin. Dial. 22, 405\u2013408 (2009).","journal-title":"Semin. Dial."},{"key":"BFnrneph201752_CR83","doi-asserted-by":"publisher","first-page":"F821","DOI":"10.1152\/ajprenal.00224.2015","volume":"309","author":"PP Kapitsinou","year":"2015","unstructured":"Kapitsinou, P. P. & Haase, V. H. Molecular mechanisms of ischemic preconditioning in the kidney. Am. J. Physiol. Renal Physiol. 309, F821\u2013F834 (2015).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201752_CR84","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10157-016-1241-4","volume":"20","author":"T Tanaka","year":"2016","unstructured":"Tanaka, T. Expanding roles of the hypoxia-response network in chronic kidney disease. Clin. Exp. Nephrol. 20, 835\u2013844 (2016).","journal-title":"Clin. Exp. Nephrol."},{"key":"BFnrneph201752_CR85","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1096\/fj.13-231837","volume":"27","author":"T Tanaka","year":"2013","unstructured":"Tanaka, T., Yamaguchi, J., Higashijima, Y. & Nangaku, M. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp\/p300-interacting transactivator with Glu\/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia. FASEB J. 27, 4059\u20134075 (2013).","journal-title":"FASEB J."},{"key":"BFnrneph201752_CR86","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/ki.2011.445","volume":"81","author":"C-Y Sun","year":"2012","unstructured":"Sun, C.-Y., Chang, S.-C. & Wu, M.-S. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int. 81, 640\u2013650 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR87","doi-asserted-by":"publisher","first-page":"F1365","DOI":"10.1152\/ajprenal.00153.2010","volume":"299","author":"A Deng","year":"2010","unstructured":"Deng, A. et al. Renal protection in chronic kidney disease: hypoxia-inducible factor activation versus angiotensin II blockade. Am. J. Physiol. Renal Physiol. 299, F1365\u2013F1373 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201752_CR88","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneph.2015.193","volume":"12","author":"PH Maxwell","year":"2015","unstructured":"Maxwell, P. H. & Eckardt, K.-U. HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond. Nat. Rev. Nephrol. 12, 157\u2013168 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201752_CR89","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2215\/CJN.13281211","volume":"7","author":"J Munoz Mendoza","year":"2012","unstructured":"Munoz Mendoza, J. et al. Fibroblast growth factor 23 and Inflammation in CKD. Clin. J. Am. Soc. Nephrol. 7, 1155\u20131162 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR90","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1046\/j.1523-1755.1998.00898.x","volume":"53","author":"D Fliser","year":"1998","unstructured":"Fliser, D. et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 53, 1343\u20131347 (1998).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR91","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1681\/ASN.2015070756","volume":"27","author":"IH de Boer","year":"2016","unstructured":"de Boer, I. H. et al. Impaired glucose and insulin homeostasis in moderate\u2013severe CKD. J. Am. Soc. Nephrol. 27, 2861\u20132871 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR92","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1172\/JCI110067","volume":"67","author":"RA DeFronzo","year":"1981","unstructured":"DeFronzo, R. A. et al. Insulin resistance in uremia. J. Clin. Invest. 67, 563\u2013568 (1981).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201752_CR93","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1172\/JCI34260","volume":"118","author":"S Schenk","year":"2008","unstructured":"Schenk, S., Saberi, M. & Olefsky, J. M. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118, 2992\u20133002 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201752_CR94","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/ERC-12-0324","volume":"20","author":"S Djiogue","year":"2013","unstructured":"Djiogue, S. et al. Insulin resistance and cancer: the role of insulin and IGFs. Endocr. Relat. Cancer 20, R1\u2013R17 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"BFnrneph201752_CR95","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/art.38986","volume":"67","author":"JT Giles","year":"2015","unstructured":"Giles, J. T. et al. Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis. Arthritis Rheumatol. 67, 626\u2013636 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrneph201752_CR96","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.271.5249.665","volume":"271","author":"GS Hotamisligil","year":"1996","unstructured":"Hotamisligil, G. S. et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665\u2013668 (1996).","journal-title":"Science"},{"key":"BFnrneph201752_CR97","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.2337\/diabetes.51.12.3391","volume":"51","author":"JJ Senn","year":"2002","unstructured":"Senn, J. J., Klover, P. J., Nowak, I. A. & Mooney, R. A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51, 3391\u20133399 (2002).","journal-title":"Diabetes"},{"key":"BFnrneph201752_CR98","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cca.2012.12.007","volume":"417","author":"A Yadav","year":"2013","unstructured":"Yadav, A., Kataria, M. A., Saini, V. & Yadav, A. Role of leptin and adiponectin in insulin resistance. Clin. Chim. Acta 417, 80\u201384 (2013).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrneph201752_CR99","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1172\/JCI200421270","volume":"114","author":"ED Muse","year":"2004","unstructured":"Muse, E. D. et al. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 114, 232\u2013239 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201752_CR100","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1096\/fj.03-0433hyp","volume":"17","author":"RH Straub","year":"2003","unstructured":"Straub, R. H. & Besedovsky, H. O. Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J. 17, 2176\u20132183 (2003).","journal-title":"FASEB J."},{"key":"BFnrneph201752_CR101","first-page":"37","volume":"2016","author":"RH Straub","year":"2016","unstructured":"Straub, R. H. & Schradin, C. Chronic inflammatory systemic diseases: an evolutionary trade-off between acutely beneficial but chronically harmful programs. Evol. Med. Public Health 2016, 37\u201351 (2016).","journal-title":"Evol. Med. Public Health"},{"key":"BFnrneph201752_CR102","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1681\/ASN.2015010022","volume":"27","author":"J He","year":"2015","unstructured":"He, J. et al. Urinary sodium and potassium excretion and CKD progression. J. Am. Soc. Nephrol. 27, 1202\u20131212 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR103","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1001\/jama.2016.4447","volume":"315","author":"KT Mills","year":"2016","unstructured":"Mills, K. T. et al. Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease. JAMA 315, 2200\u20132210 (2016).","journal-title":"JAMA"},{"key":"BFnrneph201752_CR104","doi-asserted-by":"publisher","first-page":"F606","DOI":"10.1152\/ajprenal.00269.2003","volume":"286","author":"B Rodr\u00edguez-Iturbe","year":"2004","unstructured":"Rodr\u00edguez-Iturbe, B., Vaziri, N. D., Herrera-Acosta, J. & Johnson, R. J. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am. J. Physiol. Renal Physiol. 286, F606\u2013F616 (2004).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201752_CR105","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00467-016-3349-x","volume":"32","author":"V Schatz","year":"2016","unstructured":"Schatz, V. et al. Elementary immunology: Na+ as a regulator of immunity. Pediatr. Nephrol. 32, 201\u2013210 (2016).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201752_CR106","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nm.1960","volume":"15","author":"A Machnik","year":"2009","unstructured":"Machnik, A. et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 15, 545\u2013552 (2009).","journal-title":"Nat. Med."},{"key":"BFnrneph201752_CR107","doi-asserted-by":"publisher","first-page":"579","DOI":"10.5483\/BMBRep.2010.43.9.579","volume":"43","author":"NK Lee","year":"2010","unstructured":"Lee, N. K. An evolving integrative physiology: skeleton and energy metabolism. BMB Rep. 43, 579\u2013583 (2010).","journal-title":"BMB Rep."},{"key":"BFnrneph201752_CR108","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ncpneph0124","volume":"2","author":"J Amanzadeh","year":"2006","unstructured":"Amanzadeh, J. & Reilly, R. F. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat. Clin. Pract. Nephrol. 2, 136\u2013148 (2006).","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"BFnrneph201752_CR109","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli, M. et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112, 2627\u20132633 (2005).","journal-title":"Circulation"},{"key":"BFnrneph201752_CR110","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul, C. et al. FGF23 induces left ventricular hypertrophy. J. Clin. Invest. 121, 4393\u20134408 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201752_CR111","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.abb.2014.05.022","volume":"561","author":"M Ferron","year":"2014","unstructured":"Ferron, M. & Lacombe, J. Regulation of energy metabolism by the skeleton: osteocalcin and beyond. Arch. Biochem. Biophys. 561, 137\u2013146 (2014).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFnrneph201752_CR112","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee, N. K. et al. Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456\u2013469 (2007).","journal-title":"Cell"},{"key":"BFnrneph201752_CR113","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","volume":"56","author":"M Rix","year":"1999","unstructured":"Rix, M., Andreassen, H., Eskildsen, P., Langdahl, B. & Olgaard, K. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int. 56, 1084\u20131093 (1999).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR114","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1083\/jcb.200809113","volume":"183","author":"E Hinoi","year":"2008","unstructured":"Hinoi, E. et al. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J. Cell Biol. 183, 1235\u20131242 (2008).","journal-title":"J. Cell Biol."},{"key":"BFnrneph201752_CR115","doi-asserted-by":"publisher","first-page":"37","DOI":"10.11005\/jbm.2013.20.1.37","volume":"20","author":"S-H Hong","year":"2013","unstructured":"Hong, S.-H. et al. Changes in serum osteocalcin are not associated with changes in glucose or insulin for osteoporotic patients treated with bisphosphonate. J. Bone Metab. 20, 37\u201341 (2013).","journal-title":"J. Bone Metab."},{"key":"BFnrneph201752_CR116","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/jbmr.1865","volume":"28","author":"AV Schwartz","year":"2013","unstructured":"Schwartz, A. V. et al. Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. J. Bone Miner. Res. 28, 1348\u20131354 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph201752_CR117","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","volume":"2","author":"MG Vervloet","year":"2014","unstructured":"Vervloet, M. G. et al. Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. Lancet Diabetes Endocrinol. 2, 427\u2013436 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"BFnrneph201752_CR118","doi-asserted-by":"publisher","first-page":"590","DOI":"10.2215\/CJN.06420909","volume":"5","author":"RM Holden","year":"2010","unstructured":"Holden, R. M. et al. Vitamins K and D status in stages 3\u20135 chronic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 590\u2013597 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR119","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ki.2012.477","volume":"83","author":"KM McCabe","year":"2013","unstructured":"McCabe, K. M. et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int. 83, 835\u2013844 (2013).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR120","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00198-012-2003-0","volume":"24","author":"S Okuno","year":"2013","unstructured":"Okuno, S. et al. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients. Osteoporos. Int. 24, 605\u2013612 (2013).","journal-title":"Osteoporos. Int."},{"key":"BFnrneph201752_CR121","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4149\/endo_2011_02_99","volume":"45","author":"P Patterson-Buckendahl","year":"2011","unstructured":"Patterson-Buckendahl, P. Osteocalcin is a stress-responsive neuropeptide. Endocr. Regul. 45, 99\u2013110 (2011).","journal-title":"Endocr. Regul."},{"key":"BFnrneph201752_CR122","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1074\/jbc.M113.500850","volume":"289","author":"M Kawai","year":"2014","unstructured":"Kawai, M., Kinoshita, S., Shimba, S., Ozono, K. & Michigami, T. Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent manner. J. Biol. Chem. 289, 1457\u20131466 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201752_CR123","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","volume":"22","author":"A Grabner","year":"2015","unstructured":"Grabner, A. et al. Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab. 22, 1020\u20131032 (2015).","journal-title":"Cell Metab."},{"key":"BFnrneph201752_CR124","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Guti\u00e9rrez","year":"2009","unstructured":"Guti\u00e9rrez, O. M. et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119, 2545\u20132552 (2009).","journal-title":"Circulation"},{"key":"BFnrneph201752_CR125","doi-asserted-by":"publisher","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","volume":"7","author":"B Dai","year":"2012","unstructured":"Dai, B. et al. A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. PLoS ONE 7, e44161 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrneph201752_CR126","first-page":"687","volume":"25","author":"M Wojcik","year":"2012","unstructured":"Wojcik, M. et al. The association of FGF23 levels in obese adolescents with insulin sensitivity. J. Pediatr. Endocrinol. Metab. 25, 687\u2013690 (2012).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"BFnrneph201752_CR127","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/ATVBAHA.110.214619","volume":"31","author":"MAI Mirza","year":"2011","unstructured":"Mirza, M. A. I. et al. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler. Thromb. Vasc. Biol. 31, 219\u2013227 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph201752_CR128","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1681\/ASN.2013050465","volume":"25","author":"JJ Scialla","year":"2014","unstructured":"Scialla, J. J. et al. Fibroblast growth factor-23 and cardiovascular events in CKD. J. Am. Soc. Nephrol. 25, 349\u2013360 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR129","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1681\/ASN.2014040325","volume":"26","author":"J Xie","year":"2015","unstructured":"Xie, J., Yoon, J., An, S.-W., Kuro-o, M. & Huang, C.-L. Soluble klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate. J. Am. Soc. Nephrol. 26, 1150\u20131160 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR130","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser, D. et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J. Am. Soc. Nephrol. 18, 2600\u20132608 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR131","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1681\/ASN.2012070713","volume":"24","author":"JJ Scialla","year":"2013","unstructured":"Scialla, J. J. et al. Mineral metabolites and CKD progression in African Americans. J. Am. Soc. Nephrol. 24, 125\u2013135 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR132","first-page":"1","volume":"26","author":"G Tripepi","year":"2014","unstructured":"Tripepi, G. et al. Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD. J. Am. Soc. Nephrol. 26, 1\u201310 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"Suppl. 1","key":"BFnrneph201752_CR133","doi-asserted-by":"publisher","first-page":"i54","DOI":"10.1093\/ndt\/gft342","volume":"29","author":"AB Sanz","year":"2014","unstructured":"Sanz, A. B. et al. TWEAK and the progression of renal disease: clinical translation. Nephrol. Dial. Transplant. 29 (Suppl. 1), i54\u2013i62 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR134","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2015.290","volume":"89","author":"V David","year":"2015","unstructured":"David, V. et al. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int. 89, 135\u2013146 (2015).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR135","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/eci.12588","volume":"46","author":"E Dounousi","year":"2016","unstructured":"Dounousi, E. et al. Intact FGF23 and \u03b1klotho during acute inflammation\/sepsis in CKD patients. Eur. J. Clin. Invest. 46, 234\u2013241 (2016).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFnrneph201752_CR136","doi-asserted-by":"crossref","unstructured":"Rossaint, J. et al. FGF23 signaling impairs neutrophil recruitment and host defense during CKD. 126, 962\u2013974 (2016).","DOI":"10.1172\/JCI83470"},{"key":"BFnrneph201752_CR137","doi-asserted-by":"publisher","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","volume":"307","author":"N Silswal","year":"2014","unstructured":"Silswal, N. et al. FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. Am. J. Physiol. Endocrinol. Metab. 307, E426\u2013E436 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrneph201752_CR138","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.numecd.2015.10.004","volume":"26","author":"E Dounousi","year":"2015","unstructured":"Dounousi, E. et al. Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in ckd patients. Nutr. Metab. Cardiovasc. Dis. 26, 80\u201383 (2015).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"BFnrneph201752_CR139","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","volume":"32","author":"A Lopez","year":"2004","unstructured":"Lopez, A. et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med. 32, 21\u201330 (2004).","journal-title":"Crit. Care Med."},{"key":"BFnrneph201752_CR140","first-page":"1","volume":"26","author":"GM London","year":"2014","unstructured":"London, G. M., Marchais, S. J., Gu\u00e9rin, A. P. & de Vernejoul, M.-C. Ankle\u2013brachial index and bone turnover in patients on dialysis. J. Am. Soc. Nephrol. 26, 1\u20138 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR141","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2265.2011.04133.x","volume":"75","author":"KW Ng","year":"2011","unstructured":"Ng, K. W. Regulation of glucose metabolism and the skeleton. Clin. Endocrinol. (Oxf.) 75, 147\u2013155 (2011).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrneph201752_CR142","first-page":"253","volume":"17","author":"C Zoccali","year":"2004","unstructured":"Zoccali, C. et al. Leptin and biochemical markers of bone turnover in dialysis patients. J. Nephrol. 17, 253\u2013260 (2004).","journal-title":"J. Nephrol."},{"key":"BFnrneph201752_CR143","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cytogfr.2015.12.009","volume":"27","author":"L Grgurevic","year":"2016","unstructured":"Grgurevic, L., Christensen, G. L., Schulz, T. J. & Vukicevic, S. Bone morphogenetic proteins in inflammation, glucose homeostasis and adipose tissue energy metabolism. Cytokine Growth Factor Rev. 27, 105\u2013118 (2016).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrneph201752_CR144","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1093\/ndt\/gfw066","volume":"31","author":"K Luttropp","year":"2016","unstructured":"Luttropp, K. et al. Genotypic and phenotypic predictors of inflammation in patients with chronic kidney disease. Nephrol. Dial. Transplant. 31, 2033\u20132040 (2016).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR145","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.atherosclerosis.2007.11.031","volume":"199","author":"X Li","year":"2008","unstructured":"Li, X., Yang, H.-Y. & Giachelli, C. M. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199, 271\u2013277 (2008).","journal-title":"Atherosclerosis"},{"key":"BFnrneph201752_CR146","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/ndt\/gfr609","volume":"27","author":"ER Smith","year":"2012","unstructured":"Smith, E. R. et al. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol. Dial. Transplant. 27, 1957\u20131966 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR147","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pharmthera.2015.10.003","volume":"156","author":"JM Mu\u00f1oz-F\u00e9lix","year":"2015","unstructured":"Mu\u00f1oz-F\u00e9lix, J. M., Gonz\u00e1lez-N\u00fa\u00f1ez, M., Mart\u00ednez-Salgado, C. & L\u00f3pez-Novoa, J. M. TGF-\u03b2\/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations? Pharmacol. Ther. 156, 44\u201358 (2015).","journal-title":"Pharmacol. Ther."},{"key":"BFnrneph201752_CR148","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.kint.2016.02.006","volume":"89","author":"ZA Massy","year":"2016","unstructured":"Massy, Z. A. & Drueke, T. B. Activin receptor IIA ligand trap in chronic kidney disease: 1 drug to prevent 2 complications-or even more? Kidney Int. 89, 1180\u20131182 (2016).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR149","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.2337\/dc14-0669","volume":"37","author":"G Gruden","year":"2014","unstructured":"Gruden, G., Landi, A. & Bruno, G. Natriuretic peptides, heart, and adipose tissue: new findings and future developments for diabetes research. Diabetes Care 37, 2899\u20132908 (2014).","journal-title":"Diabetes Care"},{"key":"BFnrneph201752_CR150","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1172\/JCI64526","volume":"122","author":"S Engeli","year":"2012","unstructured":"Engeli, S. et al. Natriuretic peptides enhance the oxidative capacity of human skeletal muscle. J. Clin. Invest. 122, 4675\u20134679 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201752_CR151","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.regpep.2008.02.009","volume":"148","author":"V Chiurchi\u00f9","year":"2008","unstructured":"Chiurchi\u00f9, V. et al. Brain natriuretic peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages. Regul. Pept. 148, 26\u201332 (2008).","journal-title":"Regul. Pept."},{"key":"BFnrneph201752_CR152","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/HYPERTENSIONAHA.114.05054","volume":"66","author":"D Li","year":"2015","unstructured":"Li, D. et al. Efficacy of B-type natriuretic peptide is coupled to phosphodiesterase 2A in cardiac sympathetic neurons. Hypertension 66, 190\u2013198 (2015).","journal-title":"Hypertension"},{"key":"BFnrneph201752_CR153","doi-asserted-by":"crossref","first-page":"10729","DOI":"10.1016\/S0021-9258(17)34119-4","volume":"269","author":"H Hagiwara","year":"1994","unstructured":"Hagiwara, H. et al. Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J. Biol. Chem. 269, 10729\u201310733 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201752_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/bbrc.1996.0836","volume":"223","author":"M Suda","year":"1996","unstructured":"Suda, M. et al. C-type natriuretic peptide as an autocrine\/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system. Biochem. Biophys. Res. Commun. 223, 1\u20136 (1996).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph201752_CR155","doi-asserted-by":"publisher","first-page":"18983","DOI":"10.1074\/jbc.270.32.18983","volume":"270","author":"LS Holliday","year":"1995","unstructured":"Holliday, L. S., Dean, A. D., Greenwald, J. E. & Glucks, S. L. C-type natriuretic peptide increases bone resorption in 1,25-dihydroxyvitamin D3-stimulated mouse bone marrow cultures. J. Biol. Chem. 270, 18983\u201318989 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201752_CR156","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1073\/pnas.95.5.2337","volume":"95","author":"M Suda","year":"1998","unstructured":"Suda, M. et al. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc. Natl Acad. Sci. USA 95, 2337\u20132342 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201752_CR157","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1681\/ASN.V1271508","volume":"12","author":"C Zoccali","year":"2001","unstructured":"Zoccali, C. et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J. Am. Soc. Nephrol. 12, 1508\u20131515 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR158","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrneph.2013.74","volume":"9","author":"SS Gunta","year":"2013","unstructured":"Gunta, S. S., Thadhani, R. I. & Mak, R. H. The effect of vitamin D status on risk factors for cardiovascular disease. Nat. Rev. Nephrol. 9, 337\u2013347 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201752_CR159","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.2215\/CJN.02160309","volume":"4","author":"M Johal","year":"2009","unstructured":"Johal, M. & Levin, A. Vitamin D and parathyroid hormone in general populations: understandings in 2009 and applications to chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4, 1508\u20131514 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR160","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/ndt\/gft435","volume":"29","author":"L Koppe","year":"2014","unstructured":"Koppe, L. et al. Insulin resistance in chronic kidney disease: new lessons from experimental models. Nephrol. Dial. Transplant. 29, 1666\u20131674 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR161","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/ckj\/sfv004","volume":"8","author":"R Vanholder","year":"2015","unstructured":"Vanholder, R. & Glorieux, G. The intestine and the kidneys: a bad marriage can be hazardous. Clin. Kidney J. 8, 168\u2013179 (2015).","journal-title":"Clin. Kidney J."},{"key":"BFnrneph201752_CR162","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","volume":"39","author":"J Wong","year":"2014","unstructured":"Wong, J. et al. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am. J. Nephrol. 39, 230\u2013237 (2014).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph201752_CR163","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2012","unstructured":"Vaziri, N. D. et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 83, 308\u2013315 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR164","doi-asserted-by":"publisher","unstructured":"Sumida, K. et al. Constipation and incident CKD. J. Am. Soc. Nephrol. http:\/\/dx.doi.org\/10.1681\/ASN.2016060656 (2016).","DOI":"10.1681\/ASN.2016060656"},{"key":"BFnrneph201752_CR165","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.niox.2013.02.080","volume":"30","author":"L Servillo","year":"2013","unstructured":"Servillo, L., Giovane, A., Cautela, D., Castaldo, D. & Balestrieri, M. L. The methylarginines NMMA, ADMA, and SDMA are ubiquitous constituents of the main vegetables of human nutrition. Nitric Oxide 30, 43\u201348 (2013).","journal-title":"Nitric Oxide"},{"key":"BFnrneph201752_CR166","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1073\/pnas.94.12.6474","volume":"94","author":"T Koschinsky","year":"1997","unstructured":"Koschinsky, T. et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc. Natl Acad. Sci. USA 94, 6474\u20136479 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201752_CR167","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.2215\/CJN.01720211","volume":"6","author":"E Schepers","year":"2011","unstructured":"Schepers, E. et al. Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 2374\u20132383 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR168","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1681\/ASN.2005010076","volume":"16","author":"P Ravani","year":"2005","unstructured":"Ravani, P. et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J. Am. Soc. Nephrol. 16, 2449\u20132455 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR169","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","volume":"358","author":"C Zoccali","year":"2001","unstructured":"Zoccali, C. et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358, 2113\u20132117 (2001).","journal-title":"Lancet"},{"key":"BFnrneph201752_CR170","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.2215\/CJN.11291210","volume":"6","author":"G Tripepi","year":"2011","unstructured":"Tripepi, G. et al. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. Clin. J. Am. Soc. Nephrol. 6, 1714\u20131721 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR171","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jash.2012.10.005","volume":"6","author":"M Baumann","year":"2012","unstructured":"Baumann, M. Role of advanced glycation end products in hypertension and cardiovascular risk: human studies. J. Am. Soc. Hypertens. 6, 427\u2013435 (2012).","journal-title":"J. Am. Soc. Hypertens."},{"key":"BFnrneph201752_CR172","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1073\/pnas.0812874106","volume":"106","author":"WR Wikoff","year":"2009","unstructured":"Wikoff, W. R. et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl Acad. Sci. USA 106, 3698\u20133703 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201752_CR173","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.2215\/CJN.00300113","volume":"8","author":"R Poesen","year":"2013","unstructured":"Poesen, R. et al. Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. Clin. J. Am. Soc. Nephrol. 8, 1508\u20131514 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR174","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/ASN.2010121220","volume":"22","author":"PA Aronov","year":"2011","unstructured":"Aronov, P. A. et al. Colonic contribution to uremic solutes. J. Am. Soc. Nephrol. 22, 1769\u20131776 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR175","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bone.2013.07.002","volume":"56","author":"H Tanaka","year":"2013","unstructured":"Tanaka, H. et al. p-cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways. Bone 56, 347\u2013354 (2013).","journal-title":"Bone"},{"key":"BFnrneph201752_CR176","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bone.2015.06.010","volume":"79","author":"J Hirata","year":"2015","unstructured":"Hirata, J. et al. Indoxyl sulfate exacerbates low bone turnover induced by parathyroidectomy in young adult rats. Bone 79, 252\u2013258 (2015).","journal-title":"Bone"},{"key":"BFnrneph201752_CR177","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1681\/ASN.2012030281","volume":"24","author":"A Pletinck","year":"2013","unstructured":"Pletinck, A. et al. Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall. J. Am. Soc. Nephrol. 24, 1981\u20131994 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1681\/ASN.2013101062","volume":"25","author":"R Vanholder","year":"2014","unstructured":"Vanholder, R., Schepers, E., Pletinck, A., Nagler, E. V. & Glorieux, G. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J. Am. Soc. Nephrol. 25, 1\u201311 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR179","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12882-016-0275-x","volume":"17","author":"GB Piccoli","year":"2016","unstructured":"Piccoli, G. B. et al. Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines? BMC Nephrol. 17, 76 (2016).","journal-title":"BMC Nephrol."},{"key":"BFnrneph201752_CR180","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1681\/ASN.2014010042","volume":"26","author":"G Schulman","year":"2015","unstructured":"Schulman, G. et al. Randomized placebo-controlled EPPIC trials of AST-120 in CKD. J. Am. Soc. Nephrol. 26, 1732\u20131746 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR181","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2215\/CJN.12011214","volume":"11","author":"R-H Cha","year":"2016","unstructured":"Cha, R.-H. et al. A randomized, controlled trial of oral intestinal sorbent AST-120 on renal function deterioration in patients with advanced renal dysfunction. Clin. J. Am. Soc. Nephrol. 11, 559\u2013567 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR182","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2369-15-87","volume":"15","author":"R Poesen","year":"2014","unstructured":"Poesen, R. et al. Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease. BMC Nephrol. 15, 87 (2014).","journal-title":"BMC Nephrol."},{"key":"BFnrneph201752_CR183","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1096\/fj.12-1102LTR","volume":"26","author":"K McCafferty","year":"2012","unstructured":"McCafferty, K. et al. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 26, 1727\u20131735 (2012).","journal-title":"FASEB J."},{"key":"BFnrneph201752_CR184","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201363 (2011).","journal-title":"Nature"},{"key":"BFnrneph201752_CR185","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.atherosclerosis.2015.10.091","volume":"243","author":"DM Mueller","year":"2015","unstructured":"Mueller, D. M. et al. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. Atherosclerosis 243, 638\u2013644 (2015).","journal-title":"Atherosclerosis"},{"key":"BFnrneph201752_CR186","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WHW Tang","year":"2015","unstructured":"Tang, W. H. W. et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res. 116, 448\u2013455 (2015).","journal-title":"Circ. Res."},{"key":"BFnrneph201752_CR187","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3945\/ajcn.115.129684","volume":"104","author":"RD Semba","year":"2016","unstructured":"Semba, R. D. et al. The association of serum choline with linear growth failure in young children from rural Malawi. Am. J. Clin. Nutr. 104, 191\u2013197 (2016).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrneph201752_CR188","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1089\/jmf.2014.7000","volume":"17","author":"L Galland","year":"2014","unstructured":"Galland, L. The gut microbiome and the brain. J. Med. Food 17, 1261\u20131272 (2014).","journal-title":"J. Med. Food"},{"key":"BFnrneph201752_CR189","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-med-060513-093205","volume":"66","author":"JM Brown","year":"2015","unstructured":"Brown, J. M. & Hazen, S. L. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu. Rev. Med. 66, 343\u2013359 (2015).","journal-title":"Annu. Rev. Med."},{"key":"BFnrneph201752_CR190","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu, W. et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165, 111\u2013124 (2016).","journal-title":"Cell"},{"key":"BFnrneph201752_CR191","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.taap.2011.05.015","volume":"255","author":"JR Zgoda-Pols","year":"2011","unstructured":"Zgoda-Pols, J. R. et al. Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol. Appl. Pharmacol. 255, 48\u201356 (2011).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"BFnrneph201752_CR192","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/526312a","volume":"526","author":"PA Smith","year":"2015","unstructured":"Smith, P. A. The tantalizing links between gut microbes and the brain. Nature 526, 312\u2013314 (2015).","journal-title":"Nature"},{"key":"BFnrneph201752_CR193","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2013121283","volume":"26","author":"L Dou","year":"2015","unstructured":"Dou, L. et al. The cardiovascular effect of the uremic solute indole-3 acetic acid. J. Am. Soc. Nephrol. 26, 876\u2013887 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR194","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1681\/ASN.2014121241","volume":"27","author":"S Shivanna","year":"2016","unstructured":"Shivanna, S. et al. The Aryl hydrocarbon receptor is a critical regulator of tissue factor stability and an antithrombotic target in uremia. J. Am. Soc. Nephrol. 27, 189\u2013201 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR195","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1172\/JCI200315524","volume":"112","author":"J Jankowski","year":"2003","unstructured":"Jankowski, J. et al. Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J. Clin. Invest. 112, 256\u2013264 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201752_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2215\/CJN.05240515","volume":"11","author":"M Rossi","year":"2016","unstructured":"Rossi, M. et al. Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial. Clin. J. Am. Soc. Nephrol. 11, 1\u20139 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR197","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1681\/ASN.2015040369","volume":"27","author":"L Garneata","year":"2016","unstructured":"Garneata, L., Stancu, A., Dragomir, D., Stefan, G. & Mircescu, G. Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. J. Am. Soc. Nephrol. 27, 2164\u20132176 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR198","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jacc.2008.05.029","volume":"52","author":"BZ Simkhovich","year":"2008","unstructured":"Simkhovich, B. Z., Kleinman, M. T. & Kloner, R. A. Air pollution and cardiovascular injury. J. Am. Coll. Cardiol. 52, 719\u2013726 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrneph201752_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajim.22541","volume":"59","author":"TR Sponholtz","year":"2016","unstructured":"Sponholtz, T. R., Sandler, D. P., Parks, C. G. & Applebaum, K. M. Occupational exposures and chronic kidney disease: possible associations with endotoxin and ultrafine particles. Am. J. Ind. Med. 59, 1\u201311 (2016).","journal-title":"Am. J. Ind. Med."},{"key":"BFnrneph201752_CR200","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.semdp.2015.08.001","volume":"32","author":"E Cutz","year":"2015","unstructured":"Cutz, E. Hyperplasia of pulmonary neuroendocrine cells in infancy and childhood. Semin. Diagn. Pathol. 32, 420\u2013437 (2015).","journal-title":"Semin. Diagn. Pathol."},{"key":"BFnrneph201752_CR201","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1126\/science.aaf1429","volume":"351","author":"JA Whitsett","year":"2016","unstructured":"Whitsett, J. A. & Morrisey, E. E. Inflammation. Modulating pulmonary inflammation. Science 351, 662\u2013663 (2016).","journal-title":"Science"},{"key":"BFnrneph201752_CR202","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1165\/rcmb.2013-0199OC","volume":"50","author":"X Gu","year":"2014","unstructured":"Gu, X. et al. Chemosensory functions for pulmonary neuroendocrine cells. Am. J. Respir. Cell Mol. Biol. 50, 637\u2013646 (2014).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnrneph201752_CR203","first-page":"525","volume":"46","author":"I Kasacka","year":"2008","unstructured":"Kasacka, I. Quantitative characteristics of calcitonin-producing cells in the thyroid and lungs of uremic rats. Folia Histochem. Cytobiol. 46, 525\u2013530 (2008).","journal-title":"Folia Histochem. Cytobiol."},{"key":"BFnrneph201752_CR204","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1053\/j.ajkd.2016.03.415","volume":"68","author":"SD Navaneethan","year":"2016","unstructured":"Navaneethan, S. D. et al. Obstructive and restrictive lung function measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007\u20132012. Am. J. Kidney Dis. 68, 414\u2013421 (2016).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201752_CR205","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.2215\/CJN.06970711","volume":"6","author":"G Grassi","year":"2011","unstructured":"Grassi, G. et al. Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 2620\u20132627 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"Suppl. 4","key":"BFnrneph201752_CR206","first-page":"iv11","volume":"27","author":"A Hurtado","year":"2012","unstructured":"Hurtado, A., Escudero, E., Pando, J., Sharma, S. & Johnson, R. J. Cardiovascular and renal effects of chronic exposure to high altitude. Nephrol. Dial. Transplant. 27 (Suppl. 4), iv11\u2013iv16 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR207","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S0002-9343(03)00185-2","volume":"114","author":"DM Mannino","year":"2003","unstructured":"Mannino, D. M., Ford, E. S. & Redd, S. C. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am. J. Med. 114, 758\u2013762 (2003).","journal-title":"Am. J. Med."},{"key":"BFnrneph201752_CR208","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/ki.2008.390","volume":"74","author":"PJ Scheel","year":"2008","unstructured":"Scheel, P. J., Liu, M. & Rabb, H. Uremic lung: new insights into a forgotten condition. Kidney Int. 74, 849\u2013851 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR209","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1046\/j.1525-139X.2002.00083.x","volume":"15","author":"P Stenvinkel","year":"2002","unstructured":"Stenvinkel, P. & Alvestrand, A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin. Dial. 15, 329\u2013337 (2002).","journal-title":"Semin. Dial."},{"issue":"Suppl. 1","key":"BFnrneph201752_CR210","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1681\/ASN.2004110972","volume":"16","author":"G Tripepi","year":"2005","unstructured":"Tripepi, G., Mallamaci, F. & Zoccali, C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J. Am. Soc. Nephrol. 16 (Suppl. 1), S83\u2013S88 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR211","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000356085","volume":"36","author":"C Zoccali","year":"2013","unstructured":"Zoccali, C. et al. Lung congestion as a risk factor in end-stage renal disease. Blood Purif. 36, 184\u2013191 (2013).","journal-title":"Blood Purif."},{"key":"BFnrneph201752_CR212","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1681\/ASN.2012100990","volume":"24","author":"C Zoccali","year":"2013","unstructured":"Zoccali, C. et al. Pulmonary congestion predicts cardiac events and mortality in ESRD. J. Am. Soc. Nephrol. 24, 639\u2013646 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR213","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/resp.12772","volume":"21","author":"I Blanco","year":"2016","unstructured":"Blanco, I., Piccari, L. & Barber\u00e0, J. A. Pulmonary vasculature in COPD: the silent component. Respirology 21, 984\u2013994 (2016).","journal-title":"Respirology"},{"key":"BFnrneph201752_CR214","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/ki.2015.27","volume":"88","author":"D Bolignano","year":"2015","unstructured":"Bolignano, D. et al. High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2\u20134 chronic kidney disease. Kidney Int. 88, 130\u2013136 (2015).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR215","first-page":"1","volume":"27","author":"SD Navaneethan","year":"2015","unstructured":"Navaneethan, S. D. et al. Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J. Am. Soc. Nephrol. 27, 1\u201310 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR216","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1053\/j.ajkd.2012.07.029","volume":"61","author":"D Bolignano","year":"2013","unstructured":"Bolignano, D. et al. Pulmonary hypertension in CKD. Am. J. Kidney Dis. 61, 612\u2013622 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201752_CR217","doi-asserted-by":"crossref","first-page":"e002454","DOI":"10.1161\/JAHA.115.002454","volume":"4","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Impact of obstructive sleep apnea syndrome on endothelial function, arterial stiffening, and serum inflammatory markers: an updated meta-analysis and metaregression of 18 studies. J. Am. Heart Assoc. 4, e002454 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"BFnrneph201752_CR218","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1172\/JCI70420","volume":"124","author":"F Abboud","year":"2014","unstructured":"Abboud, F. & Kumar, R. Obstructive sleep apnea and insight into mechanisms of sympathetic overactivity. J. Clin. Invest. 124, 1454\u20131457 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201752_CR219","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1086\/679995","volume":"5","author":"C Kholdani","year":"2015","unstructured":"Kholdani, C., Fares, W. H. & Mohsenin, V. Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology. Pulm. Circ. 5, 220\u2013227 (2015).","journal-title":"Pulm. Circ."},{"key":"BFnrneph201752_CR220","doi-asserted-by":"publisher","first-page":"945","DOI":"10.5665\/sleep.5660","volume":"39","author":"A Ogna","year":"2015","unstructured":"Ogna, A. et al. Sleep characteristics in early stages of chronic kidney disease in the HypnoLaus Cohort. Sleep 39, 945\u2013953 (2015).","journal-title":"Sleep"},{"key":"BFnrneph201752_CR221","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1440-1797.2009.01260.x","volume":"15","author":"JJ Sim","year":"2010","unstructured":"Sim, J. J., Rasgon, S. A. & Derose, S. F. Review article: managing sleep apnoea in kidney diseases. Nephrology (Carlton). 15, 146\u2013152 (2010).","journal-title":"Nephrology (Carlton)."},{"key":"BFnrneph201752_CR222","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1161\/01.HYP.36.6.1083","volume":"36","author":"GF DiBona","year":"2000","unstructured":"DiBona, G. F. Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 36, 1083\u20131088 (2000).","journal-title":"Hypertension"},{"key":"BFnrneph201752_CR223","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1006\/frne.1994.1010","volume":"15","author":"CW Bourque","year":"1994","unstructured":"Bourque, C. W., Oliet, S. H. & Richard, D. Osmoreceptors, osmoreception, and osmoregulation. Front. Neuroendocrinol. 15, 231\u2013274 (1994).","journal-title":"Front. Neuroendocrinol."},{"key":"BFnrneph201752_CR224","unstructured":"Stems, R. H. General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema). UpToDate https:\/\/www.uptodate.com\/contents\/general-principles-of-disorders-of-water-balance-hyponatremia-and-hypernatremia-and-sodium-balance-hypovolemia-and-edema (2017)."},{"key":"BFnrneph201752_CR225","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neuron.2010.12.028","volume":"69","author":"SG Lechner","year":"2011","unstructured":"Lechner, S. G. et al. The molecular and cellular identity of peripheral osmoreceptors. Neuron 69, 332\u2013344 (2011).","journal-title":"Neuron"},{"key":"BFnrneph201752_CR226","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1152\/physrev.00017.2003","volume":"84","author":"J Antunes-Rodrigues","year":"2004","unstructured":"Antunes-Rodrigues, J., de Castro, M., Elias, L. L., Valenca, M. M. & McCann, S. M. Neuroendocrine control body fluid metabolism. Physiol. Rev. 84, 169\u2013208 (2004).","journal-title":"Physiol. Rev."},{"key":"BFnrneph201752_CR227","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1152\/physiol.00037.2015","volume":"31","author":"FN Buijs","year":"2016","unstructured":"Buijs, F. N. et al. The circadian system: a regulatory feedback network of periphery and brain. Physiology 31, 170\u2013181 (2016).","journal-title":"Physiology"},{"key":"BFnrneph201752_CR228","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.mie.2014.10.006","volume":"552","author":"CB Peek","year":"2015","unstructured":"Peek, C. B. et al. Circadian regulation of cellular physiology. Methods Enzymol. 552, 165\u2013184 (2015).","journal-title":"Methods Enzymol."},{"key":"BFnrneph201752_CR229","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/ndt\/gft525","volume":"29","author":"G Wuerzner","year":"2014","unstructured":"Wuerzner, G., Firsov, D. & Bonny, O. Circadian glomerular function: from physiology to molecular and therapeutical aspects. Nephrol. Dial. Transplant. 29, 1475\u20131480 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR230","volume-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects","author":"RF Butterworth","year":"1999","unstructured":"Butterworth, R. F. in Basic Neurochemistry: Molecular, Cellular and Medical Aspects 6th edn (eds Siegel, G. J. et al.) (Lippincott-Raven, 1999)."},{"key":"BFnrneph201752_CR231","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1681\/ASN.2013121264","volume":"25","author":"TW Meyer","year":"2014","unstructured":"Meyer, T. W. & Hostetter, T. H. Approaches to uremia. J. Am. Soc. Nephrol. 25, 2151\u20132158 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR232","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1681\/ASN.2005010005","volume":"16","author":"M Kurella","year":"2005","unstructured":"Kurella, M. et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J. Am. Soc. Nephrol. 16, 2127\u20132133 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR233","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1097\/01.ASN.0000131529.60019.FA","volume":"15","author":"SL Seliger","year":"2004","unstructured":"Seliger, S. L. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J. Am. Soc. Nephrol. 15, 1904\u20131911 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR234","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/ndt\/gfv315","volume":"31","author":"J-M Chillon","year":"2015","unstructured":"Chillon, J.-M., Massy, Z. A. & Stengel, B. Neurological complications in chronic kidney disease patients. Nephrol. Dial. Transplant. 31, 1606\u20131614 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR235","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2337\/dc14-1231","volume":"38","author":"KM Sink","year":"2015","unstructured":"Sink, K. M. et al. Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND. Diabetes Care 38, 206\u2013212 (2015).","journal-title":"Diabetes Care"},{"key":"BFnrneph201752_CR236","doi-asserted-by":"publisher","first-page":"e0125271","DOI":"10.1371\/journal.pone.0125271","volume":"10","author":"S Degaspari","year":"2015","unstructured":"Degaspari, S. et al. Altered KLOTHO and NF-\u03baB-TNF-\u03b1 signaling are correlated with nephrectomy-induced cognitive impairment in rats. PLoS ONE 10, e0125271 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrneph201752_CR237","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nm.3898","volume":"21","author":"LK Smith","year":"2015","unstructured":"Smith, L. K. et al. \u03b22-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat. Med. 21, 932\u2013937 (2015).","journal-title":"Nat. Med."},{"key":"BFnrneph201752_CR238","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder, R. et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 63, 1934\u20131943 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR239","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5665\/sleep.4400","volume":"38","author":"YC Lee","year":"2015","unstructured":"Lee, Y. C. et al. Sleep apnea and the risk of chronic kidney disease: a nationwide population-based cohort study. Sleep 38, 213\u2013221 (2015).","journal-title":"Sleep"},{"key":"BFnrneph201752_CR240","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/thoraxjnl-2015-206970","volume":"70","author":"MZ Molnar","year":"2015","unstructured":"Molnar, M. Z. et al. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax 70, 888\u2013895 (2015).","journal-title":"Thorax"},{"key":"BFnrneph201752_CR241","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/met.2008.0093","volume":"7","author":"AD Calvin","year":"2009","unstructured":"Calvin, A. D., Albuquerque, F. N., Lopez-Jimenez, F. & Somers, V. K. Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab. Syndr. Relat. Disord. 7, 271\u2013278 (2009).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"BFnrneph201752_CR242","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/j.1523-1755.1998.00853.x","volume":"53","author":"C Zoccali","year":"1998","unstructured":"Zoccali, C. et al. Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int. 53, 1078\u20131084 (1998).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR243","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/jnr.23634","volume":"93","author":"MA Daulatzai","year":"2015","unstructured":"Daulatzai, M. A. Evidence of neurodegeneration in obstructive sleep apnea: relationship between obstructive sleep apnea and cognitive dysfunction in the elderly. J. Neurosci. Res. 93, 1778\u20131794 (2015).","journal-title":"J. Neurosci. Res."},{"key":"BFnrneph201752_CR244","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/01.CIR.0000089091.09527.B8","volume":"108","author":"A Svatikova","year":"2003","unstructured":"Svatikova, A. et al. Serum amyloid a in obstructive sleep apnea. Circulation 108, 1451\u20131454 (2003).","journal-title":"Circulation"},{"key":"BFnrneph201752_CR245","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2869.2008.00705.x","volume":"18","author":"K Yaouhi","year":"2009","unstructured":"Yaouhi, K. et al. A combined neuropsychological and brain imaging study of obstructive sleep apnea. J. Sleep Res. 18, 36\u201348 (2009).","journal-title":"J. Sleep Res."},{"key":"BFnrneph201752_CR246","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2215\/CJN.11601112","volume":"8","author":"DG Moodalbail","year":"2013","unstructured":"Moodalbail, D. G. et al. Systematic review of structural and functional neuroimaging findings in children and adults with CKD. Clin. J. Am. Soc. Nephrol. 8, 1429\u20131448 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR247","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.ajkd.2010.07.003","volume":"56","author":"K Griva","year":"2010","unstructured":"Griva, K. et al. Cognitive impairment and 7-year mortality in dialysis patients. Am. J. Kidney Dis. 56, 693\u2013703 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201752_CR248","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1371\/journal.pmed.0030208","volume":"3","author":"AC Ahn","year":"2006","unstructured":"Ahn, A. C., Tewari, M., Poon, C.-S. & Phillips, R. S. The limits of reductionism in medicine: could systems biology offer an alternative? PLoS Med. 3, e208 (2006).","journal-title":"PLoS Med."},{"key":"BFnrneph201752_CR249","unstructured":"National Institutes of Health. What is the BRAIN Initiative? NIH http:\/\/www.braininitiative.nih.gov\/ (2017)."},{"key":"BFnrneph201752_CR250","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4161\/epi.26931","volume":"9","author":"AM Zawada","year":"2014","unstructured":"Zawada, A. M. et al. Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease. Epigenetics 9, 161\u2013172 (2014).","journal-title":"Epigenetics"},{"key":"BFnrneph201752_CR251","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1681\/ASN.2010101073","volume":"22","author":"JA Moreno","year":"2011","unstructured":"Moreno, J. A. et al. The inflammatory cytokines TWEAK and TNF\u03b1 reduce renal klotho expression through NF\u03baB. J. Am. Soc. Nephrol. 22, 1315\u20131325 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR252","doi-asserted-by":"publisher","first-page":"e0121750","DOI":"10.1371\/journal.pone.0121750","volume":"10","author":"E Schepers","year":"2015","unstructured":"Schepers, E. et al. Transcriptome analysis in patients with chronic kidney disease on hemodialysis disclosing a key role for CD16+CX3CR1+ monocytes. PLoS ONE 10, e0121750 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrneph201752_CR253","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/HJH.0b013e3283441129","volume":"29","author":"E Schiffer","year":"2011","unstructured":"Schiffer, E. et al. Markers of vascular disease in plasma from patients with chronic kidney disease identified by proteomic analysis. J. Hypertens. 29, 783\u2013790 (2011).","journal-title":"J. Hypertens."},{"key":"BFnrneph201752_CR254","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/ndt\/gfv048","volume":"30","author":"PR Gajjala","year":"2015","unstructured":"Gajjala, P. R., Fliser, D., Speer, T., Jankowski, V. & Jankowski, J. Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease. Nephrol. Dial. Transplant. 30, 1814\u20131824 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR255","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/hr.2010.113","volume":"33","author":"T Toyohara","year":"2010","unstructured":"Toyohara, T. et al. Metabolomic profiling of uremic solutes in CKD patients. Hypertens. Res. 33, 944\u2013952 (2010).","journal-title":"Hypertens. Res."},{"key":"BFnrneph201752_CR256","doi-asserted-by":"publisher","first-page":"e000542","DOI":"10.1161\/JAHA.113.000542","volume":"2","author":"S Kalim","year":"2013","unstructured":"Kalim, S. et al. A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients. J. Am. Heart Assoc. 2, e000542 (2013).","journal-title":"J. Am. Heart Assoc."},{"key":"BFnrneph201752_CR257","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ki.2013.328","volume":"85","author":"M Posada-Ayala","year":"2014","unstructured":"Posada-Ayala, M. et al. Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease. Kidney Int. 85, 103\u2013111 (2014).","journal-title":"Kidney Int."},{"key":"BFnrneph201752_CR258","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth, R. A. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576\u2013585 (2013).","journal-title":"Nat. Med."},{"key":"BFnrneph201752_CR259","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/ndt\/gfk056","volume":"21","author":"MA Bain","year":"2006","unstructured":"Bain, M. A., Faull, R., Fornasini, G., Milne, R. W. & Evans, A. M. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol. Dial. Transplant. 21, 1300\u20131304 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR260","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1681\/ASN.2011121175","volume":"23","author":"F Duranton","year":"2012","unstructured":"Duranton, F. et al. Normal and pathologic concentrations of uremic toxins. J. Am. Soc. Nephrol. 23, 1258\u20131270 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201752_CR261","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/ndt\/gfv364","volume":"31","author":"K Cisek","year":"2015","unstructured":"Cisek, K., Krochmal, M., Klein, J. & Mischak, H. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease. Nephrol. Dial. Transplant. 31, 2003\u20132011 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201752_CR262","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nature09764","volume":"470","author":"ED Green","year":"2011","unstructured":"Green, E. D. et al. Charting a course for genomic medicine from base pairs to bedside. Nature 470, 204\u2013213 (2011).","journal-title":"Nature"},{"issue":"Suppl. 4","key":"BFnrneph201752_CR263","first-page":"1","volume":"10","author":"K Wanichthanarak","year":"2015","unstructured":"Wanichthanarak, K., Fahrmann, J. F. & Grapov, D. Genomic, proteomic, and metabolomic data integration strategies. Biomark. Insights 10 (Suppl. 4), 1\u20136 (2015).","journal-title":"Biomark. Insights"},{"key":"BFnrneph201752_CR264","volume-title":"GenomeMag","author":"D McMullan","year":"2016","unstructured":"McMullan, D. What is personalized medicine? GenomeMag http:\/\/genomemag.com\/what-is-personalized-medicine\/# (2016)."},{"key":"BFnrneph201752_CR265","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","volume":"369","author":"D de Zeeuw","year":"2013","unstructured":"de Zeeuw, D. et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N. Engl. J. Med. 369, 2492\u20132503 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201752_CR266","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2147\/DDDT.S52216","volume":"7","author":"S Guo","year":"2013","unstructured":"Guo, S., Zou, J. & Wang, G. Advances in the proteomic discovery of novel therapeutic targets in cancer. Drug Des. Devel. Ther. 7, 1259\u20131271 (2013).","journal-title":"Drug Des. Devel. Ther."},{"key":"BFnrneph201752_CR267","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1053\/j.ackd.2010.09.003","volume":"17","author":"ML Merchant","year":"2010","unstructured":"Merchant, M. L. Mass spectrometry in chronic kidney disease research. Adv. Chron. Kidney Dis. 17, 455\u2013468 (2010).","journal-title":"Adv. Chron. Kidney Dis."},{"key":"BFnrneph201752_CR268","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ckj\/sfv155","volume":"9","author":"T Papadopoulos","year":"2016","unstructured":"Papadopoulos, T. et al. Omics databases on kidney disease: where they can be found and how to benefit from them. Clin. Kidney J. 9, 343\u2013352 (2016).","journal-title":"Clin. Kidney J."},{"key":"BFnrneph201752_CR269","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000355788","volume":"39","author":"C Zoccali","year":"2014","unstructured":"Zoccali, C., Tripepi, G., Dounousi, E. & Mallamaci, F. Chronic kidney disease (CKD) as a systemic disease: whole body autoregulation and inter-organ cross-talk. Kidney Blood Press. Res. 39, 134\u2013141 (2014).","journal-title":"Kidney Blood Press. Res."},{"key":"BFnrneph201752_CR270","first-page":"360","volume":"4","author":"R Vanholder","year":"2016","unstructured":"Vanholder, R. et al. Clinical management of the uraemic syndrome in chronic kidney disease. lancet. Diabetes Endocrinol. 4, 360\u2013373 (2016).","journal-title":"Diabetes Endocrinol."},{"key":"BFnrneph201752_CR271","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.4049\/jimmunol.157.4.1638","volume":"157","author":"FS Dhabhar","year":"1996","unstructured":"Dhabhar, F. S., Miller, A. H., McEwen, B. S. & Spencer, R. L. Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. J. Immunol. 157, 1638\u20131644 (1996).","journal-title":"J. Immunol."},{"key":"BFnrneph201752_CR272","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0031-6997(24)01510-2","volume":"53","author":"AP Kohm","year":"2001","unstructured":"Kohm, A. P. & Sanders, V. M. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev 53, 487\u2013525 (2001).","journal-title":"Pharmacol. Rev"},{"key":"BFnrneph201752_CR273","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1749-6632.1985.tb11814.x","volume":"453","author":"HR Lieberman","year":"1985","unstructured":"Lieberman, H. R., Garfield, G., Waldhauser, F., Lynch, H. J. & Wurtman, R. J. Possible behavioral consequences of light-induced changes in melatonin availability. Ann. NY Acad. Sci. 453, 242\u2013252 (1985).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrneph201752_CR274","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.165.3892.513","volume":"165","author":"JF Sassin","year":"1969","unstructured":"Sassin, J. F. et al. Human growth hormone release: relation to slow-wave sleep and sleep-walking cycles. Science 165, 513\u2013515 (1969).","journal-title":"Science"},{"key":"BFnrneph201752_CR275","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.177.4055.1205","volume":"177","author":"JF Sassin","year":"1972","unstructured":"Sassin, J. F., Frantz, A. G., Weitzman, E. D. & Kapen, S. Human prolactin: 24-hour pattern with increased release during sleep. Science 177, 1205\u20131207 (1972).","journal-title":"Science"},{"key":"BFnrneph201752_CR276","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/intimm\/dxp109","volume":"22","author":"V Cernysiov","year":"2010","unstructured":"Cernysiov, V., Gerasimcik, N., Mauricas, M. & Girkontaite, I. Regulation of T-cell-independent and T-cell-dependent antibody production by circadian rhythm and melatonin. Int. Immunol. 22, 25\u201334 (2010).","journal-title":"Int. Immunol."},{"key":"BFnrneph201752_CR277","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bbi.2003.09.014","volume":"18","author":"S Dimitrov","year":"2004","unstructured":"Dimitrov, S., Lange, T., Fehm, H. L. & Born, J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain. Behav. Immun. 18, 368\u2013374 (2004).","journal-title":"Brain. Behav. Immun."},{"key":"BFnrneph201752_CR278","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.1523\/JNEUROSCI.17-18-07166.1997","volume":"17","author":"A Ericsson","year":"1997","unstructured":"Ericsson, A., Arias, C. & Sawchenko, P. E. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J. Neurosci. 17, 7166\u20137179 (1997).","journal-title":"J. Neurosci."},{"key":"BFnrneph201752_CR279","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1196\/annals.1351.027","volume":"1069","author":"M Cutolo","year":"2006","unstructured":"Cutolo, M. et al. Circadian rhythms: glucocorticoids and arthritis. Ann. NY Acad. Sci. 1069, 289\u2013299 (2006).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrneph201752_CR280","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-physiol-021113-170322","volume":"76","author":"GL Semenza","year":"2014","unstructured":"Semenza, G. L. Hypoxia-inducible factor 1 and cardiovascular disease. Annu. Rev. Physiol. 76, 39\u201356 (2014).","journal-title":"Annu. Rev. Physiol."},{"key":"BFnrneph201752_CR281","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4161\/cc.9.1.10371","volume":"9","author":"H Thangarajah","year":"2010","unstructured":"Thangarajah, H. et al. HIF-1alpha dysfunction in diabetes. Cell Cycle 9, 75\u201379 (2010).","journal-title":"Cell Cycle"},{"key":"BFnrneph201752_CR282","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1161\/01.ATV.0000142443.52606.81","volume":"24","author":"X-Y Zhu","year":"2004","unstructured":"Zhu, X.-Y. et al. Cortical microvascular remodeling in the stenotic kidney: role of increased oxidative stress. Arterioscler. Thromb. Vasc. Biol. 24, 1854\u20131859 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2017.52.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2017.52","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrneph.2017.52","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2017.52.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T19:49:22Z","timestamp":1750189762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2017.52"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":282,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFnrneph201752"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2017.52","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"assertion":[{"value":"24 April 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2017","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the html and pdf versions of this article originally published online the permissions line for Figure 1 was not included. This error has now been corrected online and in print.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}